European Journal of Heart Failure

Advancing knowledge in the field of heart failure management

The European Journal of Heart Failure (EJHF) is dedicated to the advancement of knowledge in the field of heart failure management.

The journal publishes reviews and editorials to improve the understanding, prevention, investigation and treatment of heart failure. Molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, as well as clinical, social and population sciences all form part of the discipline.

Submit your paper

Access your online journal

ESC Journals top-cited articles

ESC Journals top reviewers

Fast Facts

Editor-in-Chief: Michael Böhm (DE)
Current volume: 26 (year 2024)
Issues per subscription: 12
Impact Factor 2023: 16.9

Editor-in-chief History

Name	Start Date	End Date
Professor John Cleland	01/01/1999	31/12/2004
Professor Karl Swedberg	01/01/2005	31/12/2009
Professor Dirk J. Van Veldhuisen	01/01/2010	31/12/2014
Professor Marco Metra	01/01/2015	31/03/2024
Professor Michael Böhm	01/04/2024

Member Benefits

HFA Members can benefit from discounted or free online access and a print subscription to the European Journal of Heart Failure.

New: Healthcare professionals practicing in low and lower-middle income countries (World Bank classification) are now eligible for a reduced Membership rate.

Become a member

Subscriptions

Subscribe

Connect with us on X

@ESC_Journals

Updates on latest articles

Receive the table of contents in your mailbox.

Track topics and authors important to you and receive articles in your mailbox.

Sign up

For Authors

Before being published, all manuscripts go through double-blind peer review by experienced international experts.

Most recent articles from EJHF

12 Dec 2024

End‐organ protective effect of serelaxin in patients hospitalized for heart failure: Results of the biomarker substudy of Relaxin in Acute Heart Failure‐2 (RELAX‐AHF‐2)

Author(s): Adriaan A. Voors, Marco Metra, Douwe Postmus, Barry H. Greenberg, Gadi Cotter, Beth A. Davison, Iris E. Beldhuis, G. Michael Felker, Gerasimos Filippatos, Peter S. Pang, Piotr Ponikowski, Claudio Gimpelewicz, John R. Teerlink

11 Dec 2024

Tailored therapies for patients affected by systemic sclerosis with primary heart involvement: The role of rituximab

Author(s): Daniela Tomasoni, Enrico Ammirati, Marco Metra

12 Dec 2024

Management of acute decompensated valvular heart disease

Author(s): Enzo Lüsebrink, Hugo Lanz, Antonia Kellnar, Nicole Karam, Samir Kapadia, Raj Makkar, William T. Abraham, Azeem Latib, Martin Leon, Anna Sannino, Mony Shuvy, Mayra Guerrero, Neil Fam, Javed Butler, Marianna Adamo, Volker Rudolph, Gilbert H.L. Tang, Thomas J. Stocker, Karl‐Philipp Rommel, Philipp Lurz, Holger Thiele, Steffen Massberg, Fabien Praz, Bernard Prendergast, Jörg Hausleiter

10 Dec 2024

Machine learning approach to identify phenotypes in patients with ischaemic heart failure with reduced ejection fraction

Author(s): Luca Monzo, Emmanuel Bresso, Kenneth Dickstein, Bertram Pitt, John G.F. Cleland, Stefan D. Anker, Carolyn S.P. Lam, Mandeep R. Mehra, Dirk J. van Veldhuisen, Barry Greenberg, Faiez Zannad, Nicolas Girerd

Show navigation Hide navigation